Introduction: Quality assured sputum smear microscopy is a priority for Tuberculosis Control Programme to be successful to meet the global TB targets of 70% case detection and 85% treatment success rate. The SAARC TB Reference Laboratory has been conducting Panel Testing under External Quality Assurance Sputum Smear Microscopy for National TB Reference Laboratories of SAARC Member States to strengthen the Sputum Smear Microscopy. The study aims to review and analyse the Panel Testing for National Reference Laboratories of SAARC Member States.
INTRODUCTION
TB is one of the major public health problems in the SAARC Region with immense socio-economic impacts. India, Bangladesh, Pakistan and Afghanistan are among 22 high-burden countries. 1 Almost 50% the adult population of this Region has already been infected with Mycobacterium tuberculosis and is at risk of developing tuberculosis disease. In the year 2009, a total of 2.0 million of all types of TB cases were notifi ed in the SAARC region. This represents 74.07 % of the 2.7 million estimated incident cases; the 0.8 million new smear positive cases notifi ed account for 71.9 % of the 1.2 million estimates. The SAARC region carries 28.7% of the global burden of TB.
By adopting DOTS strategy, the Region has made remarkable progress in TB control. In the year 2008, SAARC Region covered 100% of its population under DOTS strategy. The Region has already achieved the target of 85% (now 88%) treatment success rate and the target of 70.0% (now 71.9%) case detection rate. 1 The World Health Organization (WHO) Stop TB strategy for tuberculosis control (DOTS) relies on a network of laboratories that provide acid fast bacilli (AFB) microscopy.
1 SAARC TB Reference Laboratory (STLR) and ten other National TB Reference Laboratories (NRLs), two each from India and Pakistan and one each from other Member States the SAARC TB Laboratory network. One of the objectives of SAARC TB and HIV/AIDS Centre (STAC) is strengthening laboratory network & improving External Quality Assessment (EQA) and supervision. 2 STRL at STAC is regularly supporting 10 National TB Reference Laboratories (NRLs) in 8 Member States in the area of quality assurance in sputum smear microscopy. Panel Testing-one of the three components for external quality assessment (EQA) or profi ciency testing has been used to assure the quality of sputum smear microscopy services since 2003.
3,4 So far, seven rounds of profi ciency testing have been completed and eighth round is ongoing. This study aims to analyse seven rounds of profi ciency tests for sputum smear microscopy within the network of National TB reference Laboratory of the SAARC region beginning from 2003 to 2010.
METHODOLOGY
The reports of seven rounds of profi ciency tests were collected and data from these reports were compiled. 2, [5] [6] [7] [8] [9] [10] The parameters that were studied were; number of Member States participated, number of slides included in each rounds, number of slides read and number of errors reported. The indicators of quality assessment of sputum smear microscopy were also calculated and the performance was analysed. The criteria of performance of the regional Panel Testing was interpreted as; >95%=Excellent, 90-95%=Satisfactory and <90%=poor. Although, quantifi cation error is considered as minor error in Panel Testing, it was taken as acceptable result for calculation of indicators in this analysis. The percentage agreement was more than 95% for 9 out of 10 participants and 100% agreement was seen for 5 laboratories (Table 2) . Similarly, sensitivity was more 90% for all laboratories and specifi city was more than 95% for all laboratories except for Afghanistan (83.33%). 
RESULTS
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DISCUSSION
WHO Stop TB strategy for tuberculosis control (DOTS) relies on a network of laboratories that provides acid fast bacilli (AFB) sputum smear microscopy. Sputum smear microscopy (SSM) is the diagnostic tool to diagnose TB at the fi eld level in the resource limited settings. The generation time for Mycobacterium tuberculosis is 18-24 hours so the culture and identifi cation needs 4-6 weeks and further 4-6 weeks for drug susceptibility test. 11 Molecular techniques are easy, rapid and of high sensitivity for TB diagnosis but they are not economical and diffi cult to adopt in resource limited countries. Hence, quality assured SSM is only the tool to bring success to TB control program in resource limited settings.
STLR and ten other NRLs of SAARC Member
States are within the SAARC TB Laboratory network and the regional Panel Testing for SSM is being regularly conducted by STRL. Total agreement of the program in the region is 98.07%. The success of TB control in the region is in part due to the quality assured SSM. By adopting DOTS strategy with a quality assured SSM, the Region has achieved the global target of 70% of case detection (region, 71.9%) and 85% treatment success (region, 88%) and has made a remarkable progress in TB control. 1 The performance of Panel Testing was excellent (98.07%). Performance of all the TB reference laboratories was more than 95% while TB Reference Laboratory of Afghanistan was less than 90%. The Panel Testing conducted in Haiti showed 60% agreement and the sensitivity was below 80% for most of the laboratories assessed. However, the scoring criteria used in these two Panel testing were different.
12 Similarly, the percentage agreement of 8 th round of Panel testing conducted at the district level in Bhutan was more than 90% for 15 out of 19 laboratories. 13 The SAARC regional quality assurance for SSM has reported 778 panel slides, 15 were incorrect reports and most of them were low false negative (n=8 Case detection through quality assured SSM and their treatment through supply of quality assured drugs ensures the success of the TB control programme. But this also has a limitation that not all TB cases can be detected through SSM. Some TB patients who are sputum smear negative can also give TB culture positive as culture is more sensitive and can detect as low as 10 bacilli/ml of sputum. 15 Introduction of recent diagnostic test like, Gene Xpert MTB/Rif to detect M. tuberculosis would be helpful to fi ght against TB and achieve global targets.
CONCLUSION
The excellent EQASSM within the SAARC TB Laboratory Network is one of the contributors of the success behind the TB case detection, high treatment success rate and successful TB control programmes in the region. EQA for culture & drug susceptibility testing is highly recommended within the STRL network to fi ght against TB.
